RSV 6120/∆NS1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RSV 6120/∆NS1, covering 2026-02-13 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children [Phase 1]